Zimbabwe has turned down a significant US health deal valued at 367 million US dollars (£272m) over five years due to Washington's request for sensitive biological samples.
This move came to light after a government memo from December was disclosed, revealing that Head of State Emmerson Mnangagwa felt the deal was "lopsided".
A government spokesman has since clarified that the United States was demanding access to genetic material for scientific study and commercial gain while was unwilling to share the resulting advantages from future treatments.
"We are forced to start the challenging and unfortunate process of winding down our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the US had provided over $1.9bn for health programmes to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has appealed for continued negotiations to find a agreement agreeable to all parties so the nation's vital HIV treatment initiative can be sustained.
Broader Implications
This development follows a similar case in neighbouring Kenya, where a high court blocked a similar health funding agreement after legal challenges were raised about the security of citizens' medical information.
After resuming office last year, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
The agency had overseen aid for the American government, but Trump argued its expenditure was "wasteful" and his government was seeking government-to-government deals to boost transparency and responsibility.
Based on statements, 16 nations in Africa have so far signed similar health pacts, representing over $18.3bn in new funding.
Specifics of the Declined Agreement
The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this collaboration might have yielded extraordinary benefits for the people of Zimbabwe, especially the 1.2 million presently receiving HIV treatment via US-supported initiatives," Tremont added.
However, government spokesperson Nick Mangwana said the proposed deal was "unequal".
"The proposal required Zimbabwe to share its genetic material and health information over an extended period, without any corresponding promise of access to any scientific breakthroughs – like new medicines or tests – that might result from that provided information," his statement read.
"In essence, our nation would supply the basic resources for medical research with no certainty that the resulting innovations would be accessible to our citizens should a future pandemic arise."
National Interest and Global Health
He also said that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were undermining systems previously established through the global organization.
The spokesperson cited its Pandemic Benefit-Sharing framework designed to deal with potential global health emergencies.
"This system is designed to guarantee that when a nation contributes its samples, the benefits – such as medicines and cures – are distributed fairly, not commercialised solely by those with the resources to create them."
These objections regarding the US deal "must not be interpreted as anti-American sentiment," he added.
"We are open to further dialogue with our US partners on how subsequent co-operation could be arranged in a way that respects the sovereignty and interests of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the government's concerns, but suggested that negotiations need to persist considering much of the country's Aids initiatives were funded by external financing.
"Where technical issues arise, such as those relating to information security or agreement terms, these can frequently be addressed via technical clarification and mutually agreed protections," the group commented.
This impasse underscores the complex debate between accepting vital foreign assistance and safeguarding national sovereignty in an increasingly interconnected world.